M, V. R. (2022) “Risk Assessment of Failures in Generic Drug Development and Approval Procedure under Competitive Generic Drug Therapy and Patent Challenge Exclusivities Provided by the United States Food and Drug Administration: Risk assessment of CGT and PC Exclusivity drugs”, Acta Marisiensis - Seria Medica, 68(1). doi: 10.2478/amma-2022-0004.